Thalidomide Induced Remission in Early-Onset Crohn's DiseaseThalidomide Induced Remission in Early-Onset Crohn's Disease
Thalidomide induced remission in children and adolescents with treatment-refractory Crohn's disease in 8 weeks in a small randomized trial. Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Rheumatology News Source Type: news
More News: Children | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Rheumatology